345
Participants
Start Date
August 31, 2004
Study Completion Date
July 31, 2007
insulin glulisine
PREMEAL ARM: Subjects randomized to this arm will receive Apidra administered three times per day 0-15 min before the three main meals; metformin (if applicable); and Lantus qd for 52 weeks.
insulin glargine
POSTMEAL ARM: Subjects randomized to this arm will receive Apidra administered three times per day immediately after a meal (20 min after the start of a meal); metformin (if applicable); and Lantus qd for 52 weeks.
Sanofi-aventis, Bridgewater
Lead Sponsor
Sanofi
INDUSTRY